Since the onset of the COVID-19 pandemic, dedicated teams at international biotech company QIAGEN have been working around the clock to develop tests for the SARS-CoV-2 virus. The company focuses on testing solutions for diagnostic labs and researchers, as well as genomic services and genome sequencing for academic researchers.
Throughout the race to bring COVID-19 under control, Fortinet has helped secure vital data—both individual information and aggregated research results—across QIAGEN’s 45 locations around the world and data centers on three continents